Skip to main navigation Skip to search Skip to main content

Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity?

  • Maria Pia De Carolis
  • , Silvia Salvi
  • , Angela Botta
  • , Antonio Lanzone
  • , Sara De Carolis

Research output: Contribution to journalArticle

Abstract

Neonatal antiphospholipid syndrome (neonatal APS) seems to be exceedingly rare, as the antiphospholipid antibodies (aPL) related thrombosis in the neonatal period. The pathogenesis of perinatal aPL related thrombosis may be explained both by the transplacental passage of the maternal antibodies and by the production of de novo antibodies by the neonate. However, few cases of neonatal APS are reported in the literature, especially regarding arterial thrombotic events. In particular, only two cases of neonatal aPL related isolated cerebral sinovenous thrombosis (CSVT) are described in the literature. Despite its frequency, CSVT results in significant mortality and morbidity, probably also due to the difficulty in early diagnosis and then in correct managing in the neonatal period. A diagnosis of neonatal APS should be considered in the evaluation of neonates with CSVT, as well as in any case of neonatal thrombosis, to correctly manage the affected neonates and counsel the mother for future pregnancies
Original languageEnglish
Pages (from-to)231-234
Number of pages4
JournalLupus
Volume24
DOIs
Publication statusPublished - 2015

Keywords

  • cerebral thrombosis
  • neonatal antiphospholipid

Fingerprint

Dive into the research topics of 'Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity?'. Together they form a unique fingerprint.

Cite this